2023 Q3 Form 10-Q Financial Statement

#000149315224001794 Filed on January 09, 2024

View on sec.gov

Income Statement

Concept 2023 Q3 2022 Q3
Revenue $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $48.99K $2.355K
YoY Change 1980.3% -97.8%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.298K $1.298K
YoY Change 0.0% -0.15%
% of Gross Profit
Operating Expenses $325.3K $339.0K
YoY Change -4.05% 212.86%
Operating Profit -$325.3K -$339.0K
YoY Change -4.05% 480.91%
Interest Expense $1.550M $279.6K
YoY Change 454.48% -308.94%
% of Operating Profit
Other Income/Expense, Net $1.550M $279.6K
YoY Change 454.47% 57.05%
Pretax Income $1.225M -$59.46K
YoY Change -2160.05% -149.7%
Income Tax
% Of Pretax Income
Net Earnings $1.225M -$59.46K
YoY Change -2160.05% -149.7%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 -$4.16
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding 14.54B shares 14.28B shares

Balance Sheet

Concept 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.19K $3.650K
YoY Change 261.37% -94.5%
Cash & Equivalents $13.19K $3.648K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $5.000K
Other Receivables $17.38K
Total Short-Term Assets $13.19K $37.96K
YoY Change -65.25% -65.29%
LONG-TERM ASSETS
Property, Plant & Equipment $16.45K $21.65K
YoY Change -23.99% -19.35%
Goodwill $2.890M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.506M $371.6K
YoY Change 1650.71%
Total Long-Term Assets $6.506M $371.6K
YoY Change 1650.71% -25.69%
TOTAL ASSETS
Total Short-Term Assets $13.19K $37.96K
Total Long-Term Assets $6.506M $371.6K
Total Assets $6.520M $409.6K
YoY Change 1491.69% -32.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.42K $31.44K
YoY Change -66.85% 637.98%
Accrued Expenses $114.6K $51.95K
YoY Change 120.56% 77.12%
Deferred Revenue
YoY Change
Short-Term Debt $3.590M $302.3K
YoY Change 1087.72% 9.39%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.673M $1.166M
YoY Change 472.47% -24.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.673M $1.166M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $6.673M $1.166M
YoY Change 472.47% -24.05%
SHAREHOLDERS EQUITY
Retained Earnings -$166.3M -$166.5M
YoY Change -0.15%
Common Stock $161.5M $164.4M
YoY Change -1.76%
Preferred Stock $1.702M $1.385M
YoY Change 22.9%
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.053M -$756.1K
YoY Change
Total Liabilities & Shareholders Equity $6.520M $409.6K
YoY Change 1491.69% -32.8%

Cashflow Statement

Concept 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $1.225M -$59.46K
YoY Change -2160.05% -149.7%
Depreciation, Depletion And Amortization $1.298K $1.298K
YoY Change 0.0% -0.15%
Cash From Operating Activities -$102.7K -$320.8K
YoY Change -67.98% 296.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $97.62K
YoY Change
NET CHANGE
Cash From Operating Activities -$102.7K -$320.8K
Cash From Investing Activities
Cash From Financing Activities $97.62K
Net Change In Cash -$5.110K -$320.8K
YoY Change -98.41%
FREE CASH FLOW
Cash From Operating Activities -$102.7K -$320.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
usd
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000932021
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
usd
CY2023Q2 GTLL Debt Discount
DebtDiscount
usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
usd
CY2022Q3 GTLL Consulting Services
ConsultingServices
usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2022Q3 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
usd
CY2022Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2023Q3 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
usd
CY2023Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
CY2022Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q3 us-gaap Stock Issued1
StockIssued1
usd
CY2022Q3 GTLL Accrual For Contingent Consideration Of Acquisition Of Foxx Trott Tango Llc
AccrualForContingentConsiderationOfAcquisitionOfFoxxTrottTangoLlc
usd
CY2023Q3 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
usd
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
000-25668
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
GLOBAL TECHNOLOGIES, LTD
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0970492
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
8 Campus Drive Suite 105
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Parsippany
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07054
CY2023Q3 dei City Area Code
CityAreaCode
(973)
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
233-5151
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q3 dei Trading Symbol
TradingSymbol
GTLL
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14688440097 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13190 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18300 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
13190 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
18300 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19909 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18611 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16454 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17752 usd
CY2023Q3 GTLL Warehouse Building
WarehouseBuilding
3600000 usd
CY2023Q2 GTLL Warehouse Building
WarehouseBuilding
15000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2890000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6506454 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
32752 usd
CY2023Q3 us-gaap Assets
Assets
6519644 usd
CY2023Q2 us-gaap Assets
Assets
51052 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10423 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
31657 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
102082 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
74984 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12500 usd
CY2023Q3 GTLL Notes Payable Third Parties Current
NotesPayableThirdPartiesCurrent
3510000 usd
CY2023Q2 GTLL Notes Payable Third Parties Current
NotesPayableThirdPartiesCurrent
390000 usd
CY2023Q3 GTLL Debt Discount
DebtDiscount
-1301918 usd
CY2023Q3 GTLL Consulting Services
ConsultingServices
250000 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
20900 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48991 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2355 usd
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
79866 usd
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
2250 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
3400000 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
860388 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1180680 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6673341 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1679571 usd
CY2023Q3 us-gaap Liabilities
Liabilities
6673341 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1679571 usd
CY2023Q3 GTLL Temporary Equity Issued Upon Conversion Value
TemporaryEquityIssuedUponConversionValue
2899488 usd
CY2023Q2 GTLL Temporary Equity Issued Upon Conversion Value
TemporaryEquityIssuedUponConversionValue
2899488 usd
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
2899488 usd
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
2899488 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14991000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14991000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14688440097 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14688440097 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14488440097 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14488440097 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1468844 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1448844 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
159999238 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
159999238 usd
CY2023Q3 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
1702285 usd
CY2023Q2 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
1472285 usd
CY2023Q3 GTLL Common Stock To Be Issued Value
CommonStockToBeIssuedValue
30000 usd
CY2023Q2 GTLL Common Stock To Be Issued Value
CommonStockToBeIssuedValue
30000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166253555 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-167478377 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-3053185 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4528007 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6519644 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51052 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
10000 usd
CY2023Q3 us-gaap Officers Compensation
OfficersCompensation
25000 usd
CY2022Q3 us-gaap Officers Compensation
OfficersCompensation
314467 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1298 usd
CY2022Q3 us-gaap Depreciation
Depreciation
1298 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
325289 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
339020 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-325289 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-339020 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1920292 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
332630 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4411 usd
CY2023Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
72099 usd
CY2022Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
7614 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
298082 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
49863 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1550111 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
279564 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1224822 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59456 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1224822 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-59456 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
14539553430 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14539553430 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
14278428060 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14278428060 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-947748 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
251098 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-59456 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-756106 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4528007 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4528007 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
250000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1224822 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1224822 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-3053185 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-3053185 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1224822 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-59456 usd
CY2023Q3 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
25000 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1920292 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
332630 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1298 usd
CY2022Q3 us-gaap Depreciation
Depreciation
1298 usd
CY2023Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
250000 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
298082 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
49863 usd
CY2022Q3 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
4411 usd
CY2022Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-21234 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15876 usd
CY2023Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
27098 usd
CY2022Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
7614 usd
CY2023Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
12500 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-102726 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-320846 usd
CY2023Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
77616 usd
CY2023Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
20000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
97616 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5110 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-320846 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18300 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
324494 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13190 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3648 usd
CY2022Q3 us-gaap Stock Issued1
StockIssued1
210833 usd
CY2023Q3 GTLL Accrual For Contingent Consideration Of Acquisition Of Foxx Trott Tango Llc
AccrualForContingentConsiderationOfAcquisitionOfFoxxTrottTangoLlc
3400000 usd
CY2023Q3 us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_800_eus-gaap--BasisOfAccounting_z6PyMBU5bHo9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE B – <span id="xdx_821_zmJblXdaxjwl">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and with Form 10-Q and Article 10 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of September 30, 2023 and the results of operations, changes in stockholders’ equity, and cash flows for the periods presented. The results of operations for the three months ended September 30, 2023 are not necessarily indicative of the operating results for the full fiscal year or any future period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2023 as filed with the Securities and Exchange Commission on December 29, 2023. The Company’s accounting policies are described in the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the year ended June 30, 2023, and updated, as necessary, in this Quarterly Report on Form 10-Q.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q3 us-gaap Cash
Cash
13190 usd
CY2023Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2023Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_z5A4Jdfj8Ap" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zC61uoJBmePa">Concentrations of Risks</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Concentration of Revenues</span></i> – For the three months ended September 30, 2023 and 2022, the Company generated $<span id="xdx_907_eus-gaap--Revenues_c20230701__20230930_zvvCwaG6TiT8"><span id="xdx_90B_eus-gaap--Revenues_c20220701__20220930_zjgonfNKlzJ1">0</span> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">revenue. All of the Company’s revenue was derived from consulting services during the year ended June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Concentration of Suppliers</span></i> – The Company relies on a limited number of suppliers and contract manufacturers. In particular, a single supplier is currently the sole manufacturer of the Company’s CBD products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p>
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29100000000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16800000000 shares
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zHcnfNhWhFFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_ze4TZM106KS1">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
10000 usd
CY2023Q3 GTLL Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Warehouse Building
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarehouseBuilding
3600000 usd
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
3610000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2890000 usd
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
6500000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2890000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2890000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36363 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36363 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19909 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18611 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16454 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17752 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1298 usd
CY2022Q3 us-gaap Depreciation
Depreciation
1298 usd
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
79866 usd
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
2250 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
860388 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1180680 usd
CY2023Q3 GTLL Preferred Stock Rank Description
PreferredStockRankDescription
All shares of the Series K Super Voting Preferred Stock shall rank (i) senior to the Corporation’s (A) Common Stock, par value $0.0001 per share (“Common Stock”), and any other class or series of capital stock of the Corporation hereafter created, except as otherwise provided in clauses (ii) and (iii) of this Section 4, (ii) pari passu with any class or series of capital stock of the Corporation hereafter created and specifically ranking, by its terms, on par with the Series K Super Voting Preferred-Stock and (iii) junior to any class or series of capital stock of the Corporation hereafter created specifically ranking, by its terms, senior to the Series K Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary.
CY2023Q3 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holders of the Class A Shares and the Class B Shares shall vote as a single class on all matters submitted to a vote of the stockholders, with each Class A Share being entitled to one (1) vote and each Class B Share being entitled to six (6) votes, except as otherwise provided by law
CY2023Q3 GTLL Stock Issued During Period Value Conversion Of Preferred Stock
StockIssuedDuringPeriodValueConversionOfPreferredStock
2899448 usd
CY2023Q3 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
0.0002
CY2023Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
14497440097 shares
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166253555 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-102726 usd

Files In Submission

Name View Source Status
0001493152-24-001794-index-headers.html Edgar Link pending
0001493152-24-001794-index.html Edgar Link pending
0001493152-24-001794.txt Edgar Link pending
0001493152-24-001794-xbrl.zip Edgar Link pending
ex10-27.htm Edgar Link pending
ex10-28.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
gtll-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
gtll-20230930_lab.xml Edgar Link unprocessable
gtll-20230930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gtll-20230930_cal.xml Edgar Link unprocessable
gtll-20230930_def.xml Edgar Link unprocessable